Search Result "atherogenic conditions."
Novel Monocyte Biomarkers of Atherogenic Conditions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5859-5864
Author(s): Alexei Gratchev, Ilja Ovsiy, Ioannis Manousaridis, Vladimir Riabov, Alexander Orekhov, Julia Kzhyshkowska
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 894-902
Author(s): Dragana Nikolic,Giuseppa Castellino,Maciej Banach,Peter P. Toth,Ekaterina Ivanova,Alexander N. Orekhov,Giuseppe Montalto,Manfredi Rizzo
Blood Serum Atherogenicity and Coronary Artery Calcification
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5884-5888
Author(s): Igor A. Sobenin, Veronica A. Myasoedova, Elena V. Anisimova, Xenia N. Pavlova, Stefan Mohlenkamp, Axel Schmermund, Rainer Seibel, Sina Berenbein, Nils Lehmann, Susanne Moebus, KarlHeinz Jockel, Alexander N. Orekhov, Raimund Erbel
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov
The Anti-Atherogenic Effects of Thiazolidinediones
Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 67-74
Author(s): Lily Stojanovska, Suzy Y. Honisett, Paul A. Komesaroff
The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 27 Year: 2013 Page: 4953-4963
Author(s): Manfredi Rizzo,Ali A. Rizvi,Emina Sudar,Sanja Soskic,Milan Obradovic,Giuseppe Montalto,Mohamed Boutjdir,Dimitri P. Mikhailidis,Esma R. Isenovic
Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Journal: Vascular Disease Prevention
Volume: 2 Issue: 2 Year: 2005 Page: 107-114
Author(s): Yehuda Kamari, Irit Avni, Ehud Grossman, Yehonatan Sharabi
Extensive Coronary Calcification: A Clinically Unrecognised Condition
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 5 Year: 2010 Page: 701-705
Author(s): Rachel Nicoll, Michael Henein